CN104873882A - Traditional Chinese medicine for treating jaundice hepatitis - Google Patents
Traditional Chinese medicine for treating jaundice hepatitis Download PDFInfo
- Publication number
- CN104873882A CN104873882A CN201510196450.7A CN201510196450A CN104873882A CN 104873882 A CN104873882 A CN 104873882A CN 201510196450 A CN201510196450 A CN 201510196450A CN 104873882 A CN104873882 A CN 104873882A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- chinese medicine
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating jaundice hepatitis, which is prepared from the following raw materials in parts by weight: 4-6 parts of vietnamese sophora root, 2-4 parts of capillary wormwood herb, 5-6 parts of poria cocos, 2-4 parts of longhairy antenoron herb, 8-10 parts of radix isatidis, 4-5 parts of radix bupleuri, 1-3 parts of glutinous rice root, 2-4 parts of immature bitter orange, 6-7 parts of rheum officinale, 4-5 parts of cape jasmine fruit, 8-10 parts of salvia miltiorrhiza, 2-4 parts of curcuma aromatica, 1-3 parts of giant knotweed, 8-10 parts of dandelion, 4-5 parts of cluster mallow leaf, 2-4 parts of tetrapanax papyriferus, 5-6 parts of chinaberry fruit, 2-3 parts of gentian, 1-3 parts of crinite pogonatherum herb, 1-3 parts of wideword parnassia herb and 1-2 parts of sprengel blueberry fruit. Owing to the scientific combination and the cooperation of the raw materials, the traditional Chinese medicine has the efficacies of clearing away heat, cooling blood, removing toxicity, dispersing blood stasis and removing dampness and jaundice. Clinical observation results show that the traditional Chinese medicine has a remarkable curative effect on jaundice hepatitis patients, the effective rate is up to 98%, and the cure rate is up to 92.5%.
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of icterohepatitis, belong to the field of Chinese medicines.
Background technology
Jaundice a kind ofly raises the sings and symptoms causing skin, mucosa and sclera to turn to be yellow due to serum mesobilirubin, is mostly the dispersivity inflammation of liver parenchymal cell.Clinical signs is that sclera, mucosa, skin and hetero-organization thereof are dyed to yellow.Comparatively general with hepatocellular jaundice and obstructive jaundice in China adult, be common in viral hepatitis, toxic hepatitis, drug-induced liver disease, various liver cirrhosis, former with secondary liver cancer and cholelithiasis etc.Current Western medicine there is no the medicine carrying out effectively treatment for jaundice.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine for the treatment of icterohepatitis.
The present invention adopts following technical scheme to achieve these goals:
The Chinese medicine for the treatment of icterohepatitis, the weight portion of its constitutive material is: Radix Sophorae Tonkinensis 4-6, Herba Artemisiae Scopariae 2-4, Poria 5-6, Herba Lysimachiae 2-4, Radix Isatidis 8-10, Radix Bupleuri 4-5, Radix Oryzae Glutinosae 1-3, Fructus Aurantii Immaturus 2-4, Radix Et Rhizoma Rhei 6-7, Fructus Gardeniae 4-5, Radix Salviae Miltiorrhizae 8-10, Radix Curcumae 2-4, Rhizoma Polygoni Cuspidati 1-3, Herba Taraxaci 8-10, Folium Malvae 4-5, Medulla Tetrapanacis 2-4, Fructus Toosendan 5-6, Radix Gentianae 2-3, Herba pogonatheri criniti 1-3, Herba parnassiae 1-3, Fructus Vaccinii Sprengelii 1-2.
The Chinese medicine for the treatment of icterohepatitis, the weight portion of its constitutive material is: Radix Sophorae Tonkinensis 5, Herba Artemisiae Scopariae 3, Poria 5.5, Herba Lysimachiae 3, Radix Isatidis 9, Radix Bupleuri 4.5, Radix Oryzae Glutinosae 2, Fructus Aurantii Immaturus 3, Radix Et Rhizoma Rhei 6.5, Fructus Gardeniae 4.5, Radix Salviae Miltiorrhizae 9, Radix Curcumae 3, Rhizoma Polygoni Cuspidati 2, Herba Taraxaci 9, Folium Malvae 4.5, Medulla Tetrapanacis 3, Fructus Toosendan 5.5, Radix Gentianae 2.5, Herba pogonatheri criniti 2, Herba parnassiae 2, Fructus Vaccinii Sprengelii 1.5.
Herba parnassiae is the herb of saxifragaceae plant Herba parnassiae; Fructus Vaccinii Sprengelii is the fruit of ericad Vaccinimsprengelii.
Consumption and usage: take each raw material by the weight portion of constitutive material, add appropriate soak by water, takes the decoction after decoction, every day potion, within 10 days, be a course for the treatment of, general 2-3 can cure a course for the treatment of.
Beneficial effect of the present invention:
Chinese medicine of the present invention is by scientific compatibility, and all medicines share the drug effect with clearing away heat and cooling blood, removing toxic substances dissipating blood stasis, dampness removing jaundice eliminating; Clinical observation result shows, Chinese medicine of the present invention is evident in efficacy to icterohepatitis patient, effective percentage up to 98%, cure rate 92.5%.
Detailed description of the invention
Embodiment 1: the Chinese medicine for the treatment of icterohepatitis, the weight portion (g) of its constitutive material is: Radix Sophorae Tonkinensis 5, Herba Artemisiae Scopariae 3, Poria 5.5, Herba Lysimachiae 3, Radix Isatidis 9, Radix Bupleuri 4.5, Radix Oryzae Glutinosae 2, Fructus Aurantii Immaturus 3, Radix Et Rhizoma Rhei 6.5, Fructus Gardeniae 4.5, Radix Salviae Miltiorrhizae 9, Radix Curcumae 3, Rhizoma Polygoni Cuspidati 2, Herba Taraxaci 9, Folium Malvae 4.5, Medulla Tetrapanacis 3, Fructus Toosendan 5.5, Radix Gentianae 2.5, Herba pogonatheri criniti 2, Herba parnassiae 2, Fructus Vaccinii Sprengelii 1.5.
Consumption and usage: take each raw material by the weight portion of constitutive material, add appropriate soak by water, takes the decoction after decoction, every day potion, within 10 days, be a course for the treatment of, general 2-3 can cure a course for the treatment of.
Model case:
Case 1: Zhang, female, 37 years old, whole skin xanthochromia, felt it is malaise, then inappetence, detest oil, nausea and vomiting, abdominal distention, even can not take food; Once from taking traditional Chinese medicine treatment, symptom was without obvious alleviation; Take Chinese medicine of the present invention, every day potion, after serveing on two courses for the treatment of, jaundice disappears to some extent, nausea and vomiting transference cure, and health rejuvenates gradually; Continue to take a course for the treatment of and carry out after treatment, recovery from illness, follow up a case by regular visits to 1 year without recurrence.
Case 2: Hu, female, 42 years old, body icteric sclera contaminated, and felt sick and detested oil, skin pruritus, and stool matter is rare, yellow skin, and red tongue is fat, white and greasy fur, and stringy and rolling pulse is diagnosed as jaundice; Take Chinese medicine of the present invention, every day potion, after serveing on two courses for the treatment of, jaundice obviously goes down, and detests oil without feeling sick, urine color is pale yellow, and stool is normal, no conscious sympton, and rear continuation takes two courses for the treatment of with consolidate curative effect, cures.
Case 3: Gong so-and-so, man, 41 years old, suffers from icterohepatitis two weeks, first occurs that urine yellow skin contaminates, then sees the xanthochromia of sclera and skin, and with heating, poor appetite, nausea and vomiting, pain that hepatic region is swollen, red tongue, yellow fur, stringy and rolling pulse number; Take Chinese medicine of the present invention, every day potion, after serveing on three courses for the treatment of, all diseases disappear entirely, cure, follow up a case by regular visits to 2 years without recurrence.
Claims (2)
1. treat a Chinese medicine for icterohepatitis, it is characterized in that the weight portion of its constitutive material is: Radix Sophorae Tonkinensis 4-6, Herba Artemisiae Scopariae 2-4, Poria 5-6, Herba Lysimachiae 2-4, Radix Isatidis 8-10, Radix Bupleuri 4-5, Radix Oryzae Glutinosae 1-3, Fructus Aurantii Immaturus 2-4, Radix Et Rhizoma Rhei 6-7, Fructus Gardeniae 4-5, Radix Salviae Miltiorrhizae 8-10, Radix Curcumae 2-4, Rhizoma Polygoni Cuspidati 1-3, Herba Taraxaci 8-10, Folium Malvae 4-5, Medulla Tetrapanacis 2-4, Fructus Toosendan 5-6, Radix Gentianae 2-3, Herba pogonatheri criniti 1-3, Herba parnassiae 1-3, Fructus Vaccinii Sprengelii 1-2.
2. the Chinese medicine for the treatment of icterohepatitis according to claim 1, is characterized in that the weight portion of its constitutive material is: Radix Sophorae Tonkinensis 5, Herba Artemisiae Scopariae 3, Poria 5.5, Herba Lysimachiae 3, Radix Isatidis 9, Radix Bupleuri 4.5, Radix Oryzae Glutinosae 2, Fructus Aurantii Immaturus 3, Radix Et Rhizoma Rhei 6.5, Fructus Gardeniae 4.5, Radix Salviae Miltiorrhizae 9, Radix Curcumae 3, Rhizoma Polygoni Cuspidati 2, Herba Taraxaci 9, Folium Malvae 4.5, Medulla Tetrapanacis 3, Fructus Toosendan 5.5, Radix Gentianae 2.5, Herba pogonatheri criniti 2, Herba parnassiae 2, Fructus Vaccinii Sprengelii 1.5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510196450.7A CN104873882A (en) | 2015-04-24 | 2015-04-24 | Traditional Chinese medicine for treating jaundice hepatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510196450.7A CN104873882A (en) | 2015-04-24 | 2015-04-24 | Traditional Chinese medicine for treating jaundice hepatitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104873882A true CN104873882A (en) | 2015-09-02 |
Family
ID=53941737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510196450.7A Withdrawn CN104873882A (en) | 2015-04-24 | 2015-04-24 | Traditional Chinese medicine for treating jaundice hepatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104873882A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107875317A (en) * | 2017-12-26 | 2018-04-06 | 广西壮要方医院有限公司 | A kind of medicine for treating jaundice |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1349823A (en) * | 2001-10-25 | 2002-05-22 | 王同生 | Making process of enzyme degrading oral liquid |
-
2015
- 2015-04-24 CN CN201510196450.7A patent/CN104873882A/en not_active Withdrawn
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1349823A (en) * | 2001-10-25 | 2002-05-22 | 王同生 | Making process of enzyme degrading oral liquid |
Non-Patent Citations (1)
| Title |
|---|
| 李爱民: "金茵退黄汤治疗急性黄疸型肝炎89例", 《中医研究》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107875317A (en) * | 2017-12-26 | 2018-04-06 | 广西壮要方医院有限公司 | A kind of medicine for treating jaundice |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103301439B (en) | Traditional Chinese medicine composition for treating chronic enteritis and preparation method thereof | |
| CN103316174A (en) | Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof | |
| CN103721024B (en) | A kind of Chinese medicine composition treating chronic rhinitis | |
| CN104721333A (en) | Traditional Chinese medicine composition for treating constipation | |
| CN102512617B (en) | Chinese herbal preparation for treating psoriasis | |
| CN103417792A (en) | Traditional Chinese medicine for treating eczema | |
| CN101361949B (en) | Traditional Chinese medicine for treating gynaecologic emmeniopathy | |
| CN103251864A (en) | Chinese medicament for treating pneumonia and preparation method thereof | |
| CN103768358B (en) | A kind of Chinese medicine composition for the treatment of chronic prostatitis | |
| CN104873882A (en) | Traditional Chinese medicine for treating jaundice hepatitis | |
| CN103505650B (en) | Traditional Chinese medicine composition for treating acute pancreatitis | |
| CN103550498B (en) | A kind of Chinese medicine composition for the treatment of constipation | |
| CN105456924A (en) | Traditional Chinese medicine preparation containing Folium Artemisiae Argyi and having functions of promoting circulation and removing stasis and preparation method thereof | |
| CN102188644B (en) | Traditional Chinese medicine for treating cancers | |
| CN104645192A (en) | Chinese medicine composition for treating prostatitis | |
| CN103977111B (en) | A kind of Chinese medicine for the treatment of chronic hepatitis | |
| CN101966329A (en) | Medicament for treating rash | |
| CN104784406A (en) | Traditional Chinese medicine composition for treating rectal cancer and preparation method | |
| CN104958746A (en) | Foot bath composition for treating constipation and preparation method thereof | |
| CN104707053A (en) | Traditional Chinese medicine composition for curing cervicitis | |
| CN104940814A (en) | Composition for treating psoriasis and preparation method of composition | |
| CN104906490A (en) | Traditional Chinese medicine composition for treating chronic cholecystitis | |
| CN104840757A (en) | Traditional Chinese medicine preparation for alleviating dysmenorrheal and preparation method | |
| CN104069404A (en) | Traditional Chinese medicine composition for treating oxyhepatitis or chronic hepatitis | |
| CN103736062A (en) | Traditional Chinese medicine composition for treating colitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20150902 |